Discovery of metabolomics biomarkers for early detection of nephrotoxicity. - Wikidata - awgldk - TriplyDB

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

http://www.wikidata.org/entity/Q46043673

about

Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicity alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population Organization of GC/MS and LC/MS metabolomics data into chemical libraries Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review Systemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomics Exposure of clinical MRSA heterogeneous strains to β-lactams redirects metabolism to optimize energy production through the TCA cycle Altering the Mitochondrial Fatty Acid Synthesis (mtFASII) Pathway Modulates Cellular Metabolic States and Bioactive Lipid Profiles as Revealed by Metabolomic Profiling Metabolomics in the study of kidney diseases Analyzing LC/MS metabolic profiling data in the context of existing metabolic networks.Preprocessing of NMR metabolomics data.A biomarker found in cadmium exposed residents of Thailand by metabolome analysis.Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling.Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study Serum metabolomic profiling and incident CKD among African Americans Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline.Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.Bisphenol A alters n-6 fatty acid composition and decreases antioxidant enzyme levels in rat testes: a LC-QTOF-based metabolomics study.Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum.Influence of pistachios on performance and exercise-induced inflammation, oxidative stress, immune dysfunction, and metabolite shifts in cyclists: a randomized, crossover trial.ADEMA: an algorithm to determine expected metabolite level alterations using mutual information.A metabolomic approach to identifying platinum resistance in ovarian cancer.MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor Cells.Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice Mass spectrometric imaging of metabolites in kidney tissues from rats treated with furosemide.Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue Toxic Markers of Matrine Determined Using (1) H-NMR-Based Metabolomics in Cultured Cells In Vitro and Rats In Vivo.Serum metabolic changes in rats after intragastric administration of dextromethorphan.Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain The 6R's of drug induced nephrotoxicity High-Resolution Metabolomics: Review of the Field and Implications for Nursing Science and the Study of Preterm Birth Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis Potential metabolite markers of schizophrenia.Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets.Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers.Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.

P2860

Q21089700-0181E9B5-CFED-427E-B7F4-51460A7A0802 Q21136353-5C0FE090-F186-4895-9461-9BFCF4EDAE9C Q27702050-72C23524-ACA7-41CC-989E-C2B139CC860F Q28083342-617C3777-DCE5-453A-9CC7-FBE33DFDDB22 Q28485956-A749216D-43D0-46B2-B998-47386B59B93A Q28535076-61ECF4BD-CAD1-408F-9DFC-D476A71A28DB Q28550692-A5DE8320-A13C-4525-B094-4B13B3258C35 Q30066455-702229B4-DB8D-4ED4-868C-7E39A7E8C3C8 Q30665314-5A43A7DE-5AC0-41B3-9CEB-221E0425B383 Q30903618-6C82F47D-D87B-48C9-AE19-9845442D3A50 Q33627979-9F1F41BA-802C-466E-95C0-2B2674330DA3 Q33781082-25929D7F-C26B-412C-9755-1081557CCBF7 Q33810793-26DEC7AB-B4C8-44C6-BD1E-D7C0549CD99F Q34008968-9022089F-AAAB-4FD7-90D3-94DD3AA91935 Q34017163-B518D7BC-B4E7-41AB-8CE8-1B74AD1E6F66 Q34039254-A14DA606-9684-45F1-AA64-9D9562B00F41 Q34425044-45722D34-AF92-4428-8249-B60778E9649A Q34437046-05186494-8109-4D12-A617-FD529A8DD612 Q34448525-B7E10AEE-4B79-45EA-85B5-4D0B5A8A3542 Q34557978-54733C93-6AF1-457B-BA94-8850B863E4D5 Q35404082-B1B52698-33F6-49EC-BB05-347D988ED3F5 Q35646359-4BC41058-DF3E-4934-B690-C8200ED03AE2 Q35677431-E943D493-00E0-4340-8072-D0C1BF52E9E9 Q35824916-750279B8-CF2D-4EC0-8627-3FD5525644B3 Q35951938-E6BA1146-D28E-4AFD-9CB5-16F02CA2D5AE Q35956425-76E9944D-545E-4283-BA87-741DE818385C Q36054738-737EECFC-1272-40E9-AA9E-82E77828F99A Q36104696-34A5BE3B-CF2D-4182-A2F4-38500EFA670E Q36173652-4F1A1EC7-6661-4FA1-81B0-DC3F1386BFD6 Q36333140-F359A195-65F9-4117-84A6-4F0C0200E294 Q36387102-3BEBC8B3-BB73-459B-81A4-34871871526D Q36407218-F32EE43C-EB2F-4C18-B377-0FF30CF796E5 Q36479055-92FB0BEF-BE89-4471-8A7E-80BE4D065C83 Q36522360-8DAB4E35-74D7-44D7-AC44-6A6E889E326A Q36867636-720B5AB9-8ADD-4B43-A2FE-0D36C2E3F4C9 Q36906135-5F6F71B8-55B6-4979-8C92-4363B74985BA Q36910790-F3F6A4CC-5C77-4853-97DF-D086EB74B05E Q36934990-363D7DD9-04BE-4AC1-9E99-DBB595F8D172 Q37168478-FC029CDC-9EC7-4619-9277-7F9B1FD5D967 Q37334196-D509812E-F253-4F95-956B-7549BF658EE0

P2860

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

http://www.wikidata.org/entity/Q46043673

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

@en

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

@nl

type

label

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

@en

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

@nl

prefLabel

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

@en

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

@nl

P1433

Q46043673-D2332286-A46A-44CF-910D-2E4D1ED113E5

P1476

Q46043673-7DD63D79-51BD-455B-A282-92788382221E

P2093

Q46043673-0082C4CC-11F6-4948-AF60-A65EE2E00656

Q46043673-26E3FEC6-58C3-4E9E-BC42-BEAAA51BDE16

Q46043673-4BA8C4F5-EEBC-4607-8EC0-67008314D561

Q46043673-74C7DF5C-D8D2-4E03-BABE-FBC7DA4469F7

Q46043673-C4FB5D92-CE89-438E-8C14-22D81F6BDC67

Q46043673-D28116E2-EDC1-42FC-A943-C3F24F495207

P304

Q46043673-B4CEA5B1-F7AD-4542-BC67-E5223F210317

P31

Q46043673-E9E20E09-2C34-435A-8C5C-26A8CCD7285D

P356

Q46043673-2C733007-A656-46E5-BA1A-4B364D0E1DF7

P407

Q46043673-D115E9BC-FFF1-4E58-B3CB-6AC02B996E43

P433

Q46043673-13CEDE0F-9DB0-4832-9BA1-89E93FE3494D

P478

Q46043673-BA2AA98F-05C1-4534-9140-6141BD880B92

P50

Q46043673-1E90457D-9382-4277-9148-4D5EE7038A9B

P577

Q46043673-14AEDFD3-E905-4FE0-ACA4-9852E70FBA4D

P5875

Q46043673-9A76A644-530F-4080-934D-7B1B6774BCA5

P698

Q46043673-D3918398-BFC4-4DF1-9E19-498632A2749D

P356

0192623309332992

P1433

Toxicologic Pathology

P1476

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.

@en

P2093

Abraham Nyska

http://www.w3.org/2001/XMLSchema#string

Doron Shinar

http://www.w3.org/2001/XMLSchema#string

Kurt J Boudonck

http://www.w3.org/2001/XMLSchema#string

Lilla Keresztes

http://www.w3.org/2001/XMLSchema#string

László Német

http://www.w3.org/2001/XMLSchema#string

Moti Rosenstock

http://www.w3.org/2001/XMLSchema#string

P304

280-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0192623309332992

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Matthew W. Mitchell

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24311692

http://www.w3.org/2001/XMLSchema#string

P698

19380839

http://www.w3.org/2001/XMLSchema#string